E533-0335 Screening compound: N-cyclopentyl-6-(furan-2-yl)-3-methyl-2-[3-(morpholin-4-yl)propyl]-1-oxo-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-3-carboxamide

E533-0335 Screening compound: N-cyclopentyl-6-(furan-2-yl)-3-methyl-2-[3-(morpholin-4-yl)propyl]-1-oxo-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-3-carboxamide
E533-0335 Screening compound: N-cyclopentyl-6-(furan-2-yl)-3-methyl-2-[3-(morpholin-4-yl)propyl]-1-oxo-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E533-0335
N-cyclopentyl-6-(furan-2-yl)-3-methyl-2-[3-(morpholin-4-yl)propyl]-1-oxo-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E533-0335

Molecular Formula

C25H34N4O4 (C25 H34 N4 O4)

Compound Name

N-cyclopentyl-6-(furan-2-yl)-3-methyl-2-[3-(morpholin-4-yl)propyl]-1-oxo-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-3-carboxamide

IUPAC name

N-cyclopentyl-6-(furan-2-yl)-3-methyl-2-[3-(morpholin-4-yl)propyl]-1-oxo-1H2H3H4H-pyrrolo[12-a]pyrazine-3-carboxamide

SMILES

CC(Cn1c2ccc1-c1ccco1)(C(NC1CCCC1)=O)N(CCCN1CCOCC1)C2=O

InChI

InChI=1S/C25H34N4O4/c1-25(24(31)26-19-6-2-3-7-19)18-28-20(22-8-4-15-33-22)9-10-21(28)23(30)29(25)12-5-11-27-13-16-32-17-14-27/h4,8-10,15,19H,2-3,5-7,11-14,16-18H2,1H3,(H,26,31)/t25-/m0/s1

InChI Key

MEKRRWVFSAOTMX-VWLOTQADSA-N

MDL Number (MFCD)

MFCD14896027

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

454.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.791

Distribution Coefficient, logD

2.566

Water Solubility, LogSw

-3.01

Polar Surface Area

61.030

Acid Dissociation Constant (pKa)

15.33

Base Dissociation Constant (pKb)

7.23

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

60.00

E533-0335 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cyclic Ugi PPI Library (9586 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with E533-0335 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E533-0335?
Check Price and Availability of E533-0335, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E533-0335 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E533-0335
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E533-0335
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E533-0335 available by request